Clinical significance of PCDH10 promoter methylation in diffuse large B-cell lymphoma.

Wenting HuangXuemin XueLing ShanTian QiuLei GuoJian-Ming YingNing Lu

Published in: BMC cancer (2017)

PCDH10 methylation status could serve as a valuable biomarker for risk classification, and a potential therapeutic target for demethylating drugs in DLBCL in the future.

Keyphrases

diffuse large b cell lymphoma
dna methylation
epstein barr virus
genome wide
machine learning
gene expression
deep learning
current status
transcription factor
risk assessment